Pneumococcal Disease Severity Not Limited to Elderly; Doctors Warn Smokers, Chronic Illness Patients, Frequent Travelers to Be Cautious

Pneumonia ranks as the third leading cause of death in Taiwan, and Streptococcus pneumoniae is the primary bacterium causing invasive pneumococcal disease (IPD). Doctors are urging vigilance, emphasizing that severe pneumococcal infections are not exclusive to the elderly. Individuals with diabetes, cardiovascular diseases, chronic lung conditions, those who smoke long-term, and frequent business or leisure travelers are at a higher risk, even if they are young adults aged 18 to 49. These infections can lead to serious conditions like pneumonia, bacteremia, sepsis, and meningitis.

“

Pneumococcal severe illness is not exclusive to the elderly; individuals with diabetes, cardiovascular diseases, chronic lung diseases, long-term smokers, and frequent business or leisure travelers should also be vigilant about prevention.

Taiwan currently offers free pneumococcal vaccinations for infants and individuals aged 65 and above. However, many healthy adults underestimate the threat, believing their youth and good health protect them from severe illness. Dr. Lee Ping-ying, chairman of the Taiwan Vaccine Promotion Association, noted that beyond the elderly and infants, those with compromised immune systems, chronic illnesses, or high-risk environments should also consider preventative measures. He stressed that individuals under significant work and family stress, often referred to as the "sandwich generation," should actively discuss prevention strategies with their doctor.

“

Many healthy adults still believe they are young and healthy, making them less likely to get infected or develop severe illness, thus underestimating the disease's threat.

Infectious disease experts are observing a phenomenon known as "serotype replacement" in pneumococcal infections. As widespread vaccination reduces the prevalence of older strains, newer strains like 15A, 23A, and 35B, which are not covered by older vaccines, are becoming more common causes of severe infections in adults. New-generation conjugate vaccines are designed to include these emerging strains, aiming to close the protection gap caused by serotype replacement. These updated vaccines offer broader coverage against the main serotypes responsible for adult IPD, with one new vaccine reportedly covering over 80% of major strains.

“

Newer pneumococcal conjugate vaccines not only increase the number of covered serotypes but are also selected based on recent global and Taiwanese epidemiological data for adult invasive pneumococcal disease, incorporating emerging pathogenic serotypes.

Furthermore, the vaccination process for adults is becoming more streamlined. Previously, a two-dose strategy involving PCV13 or PCV15 followed by PPV23 a year later was common, leading to many not completing the series. Newer single-dose vaccines like PCV20 and PCV21 simplify the regimen and are expected to increase vaccination completion rates. Experts advise that adult pneumococcal protection is becoming more personalized. The choice of vaccine should be based on an individual's health status, chronic disease risk, and local epidemiological trends, in consultation with a physician, to maximize protective effects.

“

Adult pneumococcal protection is gradually becoming more precise; vaccine choice should not just be about 'whether to get vaccinated,' but should be discussed with a doctor based on individual health status, chronic disease risk, and Taiwanese epidemiological trends to enhance protection.